Sodium in PDB 8gf8: Cryo-Em Structure of Human TRPV1 in CNW11 Nanodisc and Soybean Lipids
Sodium Binding Sites:
The binding sites of Sodium atom in the Cryo-Em Structure of Human TRPV1 in CNW11 Nanodisc and Soybean Lipids
(pdb code 8gf8). This binding sites where shown within
5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the
Cryo-Em Structure of Human TRPV1 in CNW11 Nanodisc and Soybean Lipids, PDB code: 8gf8:
Jump to Sodium binding site number:
1;
2;
Sodium binding site 1 out
of 2 in 8gf8
Go back to
Sodium Binding Sites List in 8gf8
Sodium binding site 1 out
of 2 in the Cryo-Em Structure of Human TRPV1 in CNW11 Nanodisc and Soybean Lipids
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 1 of Cryo-Em Structure of Human TRPV1 in CNW11 Nanodisc and Soybean Lipids within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na1211
b:74.3
occ:1.00
|
O
|
C:GLY644
|
2.4
|
10.9
|
1.0
|
O
|
A:GLY644
|
2.4
|
10.4
|
1.0
|
O
|
D:GLY644
|
2.4
|
9.8
|
1.0
|
O
|
B:GLY644
|
2.4
|
11.4
|
1.0
|
NA
|
A:NA1212
|
2.6
|
53.1
|
1.0
|
HA3
|
A:GLY644
|
2.8
|
10.4
|
1.0
|
HA3
|
C:GLY644
|
2.8
|
10.9
|
1.0
|
HA3
|
D:GLY644
|
2.9
|
9.8
|
1.0
|
HA3
|
B:GLY644
|
2.9
|
11.4
|
1.0
|
C
|
C:GLY644
|
3.3
|
10.9
|
1.0
|
C
|
A:GLY644
|
3.3
|
10.4
|
1.0
|
C
|
D:GLY644
|
3.3
|
9.8
|
1.0
|
C
|
B:GLY644
|
3.4
|
11.4
|
1.0
|
CA
|
C:GLY644
|
3.5
|
10.9
|
1.0
|
CA
|
A:GLY644
|
3.5
|
10.4
|
1.0
|
CA
|
D:GLY644
|
3.5
|
9.8
|
1.0
|
CA
|
B:GLY644
|
3.6
|
11.4
|
1.0
|
HA2
|
A:GLY644
|
3.9
|
10.4
|
1.0
|
HA2
|
C:GLY644
|
3.9
|
10.9
|
1.0
|
HA2
|
B:GLY644
|
3.9
|
11.4
|
1.0
|
HA2
|
D:GLY644
|
3.9
|
9.8
|
1.0
|
O
|
C:ILE643
|
4.3
|
11.4
|
1.0
|
O
|
A:ILE643
|
4.3
|
11.9
|
1.0
|
HG2
|
C:MET645
|
4.3
|
10.0
|
1.0
|
HG2
|
A:MET645
|
4.4
|
10.5
|
1.0
|
O
|
D:ILE643
|
4.4
|
10.8
|
1.0
|
HG2
|
D:MET645
|
4.4
|
9.6
|
1.0
|
O
|
B:ILE643
|
4.4
|
13.0
|
1.0
|
HG2
|
B:MET645
|
4.4
|
11.7
|
1.0
|
SD
|
C:MET645
|
4.5
|
10.0
|
1.0
|
SD
|
A:MET645
|
4.5
|
10.5
|
1.0
|
SD
|
D:MET645
|
4.5
|
9.6
|
1.0
|
SD
|
B:MET645
|
4.5
|
11.7
|
1.0
|
N
|
C:MET645
|
4.5
|
10.0
|
1.0
|
N
|
A:MET645
|
4.5
|
10.5
|
1.0
|
N
|
D:MET645
|
4.6
|
9.6
|
1.0
|
N
|
B:MET645
|
4.6
|
11.7
|
1.0
|
HA
|
C:MET645
|
4.7
|
10.0
|
1.0
|
HA
|
A:MET645
|
4.7
|
10.5
|
1.0
|
N
|
C:GLY644
|
4.7
|
10.9
|
1.0
|
N
|
A:GLY644
|
4.7
|
10.4
|
1.0
|
HA
|
B:MET645
|
4.7
|
11.7
|
1.0
|
HA
|
D:MET645
|
4.7
|
9.6
|
1.0
|
N
|
D:GLY644
|
4.8
|
9.8
|
1.0
|
N
|
B:GLY644
|
4.8
|
11.4
|
1.0
|
CG
|
C:MET645
|
5.0
|
10.0
|
1.0
|
CG
|
A:MET645
|
5.0
|
10.5
|
1.0
|
C
|
C:ILE643
|
5.0
|
11.4
|
1.0
|
C
|
A:ILE643
|
5.0
|
11.9
|
1.0
|
CG
|
D:MET645
|
5.0
|
9.6
|
1.0
|
|
Sodium binding site 2 out
of 2 in 8gf8
Go back to
Sodium Binding Sites List in 8gf8
Sodium binding site 2 out
of 2 in the Cryo-Em Structure of Human TRPV1 in CNW11 Nanodisc and Soybean Lipids
Mono view
Stereo pair view
|
A full contact list of Sodium with other atoms in the Na binding
site number 2 of Cryo-Em Structure of Human TRPV1 in CNW11 Nanodisc and Soybean Lipids within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Na1212
b:53.1
occ:1.00
|
NA
|
A:NA1211
|
2.6
|
74.3
|
1.0
|
HA3
|
C:GLY644
|
2.7
|
10.9
|
1.0
|
HA3
|
A:GLY644
|
2.8
|
10.4
|
1.0
|
HA3
|
B:GLY644
|
2.8
|
11.4
|
1.0
|
HA3
|
D:GLY644
|
2.8
|
9.8
|
1.0
|
CA
|
C:GLY644
|
3.6
|
10.9
|
1.0
|
CA
|
A:GLY644
|
3.7
|
10.4
|
1.0
|
CA
|
B:GLY644
|
3.7
|
11.4
|
1.0
|
CA
|
D:GLY644
|
3.7
|
9.8
|
1.0
|
HA2
|
C:GLY644
|
3.8
|
10.9
|
1.0
|
HA2
|
A:GLY644
|
3.9
|
10.4
|
1.0
|
HA2
|
D:GLY644
|
3.9
|
9.8
|
1.0
|
HA2
|
B:GLY644
|
3.9
|
11.4
|
1.0
|
O
|
C:GLY644
|
4.2
|
10.9
|
1.0
|
O
|
B:GLY644
|
4.2
|
11.4
|
1.0
|
O
|
D:GLY644
|
4.2
|
9.8
|
1.0
|
O
|
A:GLY644
|
4.2
|
10.4
|
1.0
|
OH
|
C:TYR672
|
4.4
|
19.1
|
1.0
|
OH
|
D:TYR672
|
4.4
|
11.0
|
1.0
|
C
|
C:GLY644
|
4.4
|
10.9
|
1.0
|
OH
|
A:TYR672
|
4.4
|
12.3
|
1.0
|
O
|
C:ILE643
|
4.4
|
11.4
|
1.0
|
OH
|
B:TYR672
|
4.5
|
13.5
|
1.0
|
N
|
C:GLY644
|
4.5
|
10.9
|
1.0
|
C
|
B:GLY644
|
4.5
|
11.4
|
1.0
|
C
|
A:GLY644
|
4.5
|
10.4
|
1.0
|
C
|
D:GLY644
|
4.5
|
9.8
|
1.0
|
O
|
A:ILE643
|
4.5
|
11.9
|
1.0
|
O
|
B:ILE643
|
4.5
|
13.0
|
1.0
|
O
|
D:ILE643
|
4.5
|
10.8
|
1.0
|
N
|
A:GLY644
|
4.6
|
10.4
|
1.0
|
N
|
B:GLY644
|
4.6
|
11.4
|
1.0
|
N
|
D:GLY644
|
4.6
|
9.8
|
1.0
|
HE1
|
C:TYR672
|
4.6
|
19.1
|
1.0
|
HE1
|
A:TYR672
|
4.7
|
12.3
|
1.0
|
HE1
|
D:TYR672
|
4.7
|
11.0
|
1.0
|
HE1
|
B:TYR672
|
4.7
|
13.5
|
1.0
|
C
|
C:ILE643
|
4.8
|
11.4
|
1.0
|
HH
|
C:TYR672
|
4.8
|
19.1
|
1.0
|
HH
|
D:TYR672
|
4.8
|
11.0
|
1.0
|
HH
|
A:TYR672
|
4.8
|
12.3
|
1.0
|
C
|
A:ILE643
|
4.8
|
11.9
|
1.0
|
C
|
B:ILE643
|
4.8
|
13.0
|
1.0
|
HH
|
B:TYR672
|
4.9
|
13.5
|
1.0
|
C
|
D:ILE643
|
4.9
|
10.8
|
1.0
|
|
Reference:
A.Neuberger,
M.Oda,
Y.A.Nikolaev,
K.D.Nadezhdin,
E.O.Gracheva,
S.N.Bagriantsev,
A.I.Sobolevsky.
Human TRPV1 Structure and Inhibition By the Analgesic Sb-366791. Nat Commun V. 14 2451 2023.
ISSN: ESSN 2041-1723
PubMed: 37117175
DOI: 10.1038/S41467-023-38162-9
Page generated: Wed Oct 9 12:03:06 2024
|